Haploidentical Stem Cell Transplantation With Post-Transplantation Cyclophosphamide for Aggressive Lymphomas: How Far Have We Come and Where Are We Going?

Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) with post-transplant cyclophosphamide (PTCy) offers universal donor availability and can potentially cure relapsed or primary refractory Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). However, a conditioning regimen intensity...

Descripción completa

Detalles Bibliográficos
Autor principal: Patel, Dilan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396776/
https://www.ncbi.nlm.nih.gov/pubmed/30834047
http://dx.doi.org/10.14740/wjon1164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396776/
https://www.ncbi.nlm.nih.gov/pubmed/30834047
http://dx.doi.org/10.14740/wjon1164

Ejemplares similares